Remus Pharmaceuticals Limited (NSE:REMUS)

Remus Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	72.3	47.2	30.38	11.49	8.31
Short-Term Investments	200.4	202.4	-	-	-
Cash & Short-Term Investments	272.7	249.6	30.38	11.49	8.31
Cash Growth	9.25%	721.54%	164.51%	38.30%	-30.68%
Accounts Receivable	1,080	1,153	48.48	29.15	36.04
Receivables	1,290	1,335	48.48	29.15	36.04
Inventory	515.6	431.1	2.87	15.89	11.51
Prepaid Expenses	3.2	0.4	0.49	0.07	-
Other Current Assets	131.9	107.7	31.22	20.34	19.15
Total Current Assets	2,214	2,123	113.44	76.94	75
Property, Plant & Equipment	68.3	48.6	25.13	3.09	3.92
Long-Term Investments	1,953	1,064	206.16	30.68	0.67
Goodwill	87.3	87.3	-	-	-
Other Intangible Assets	2.6	2.1	0.5	-	-
Long-Term Deferred Tax Assets	-	-	1.27	0.41	0.6
Other Long-Term Assets	1.2	5.9	0.12	47.49	30.31
Total Assets	4,326	3,331	346.61	158.6	110.5
Accounts Payable	712.9	937.1	35.31	46.73	51.59
Accrued Expenses	14.6	10.4	8.61	2.75	9.63
Short-Term Debt	171.2	83.4	6.38	-	-
Current Portion of Long-Term Debt	3.6	2.1	2.16	0.93	0.87
Current Portion of Leases	5.1	5.1	-	-	-
Current Income Taxes Payable	28.1	14.4	6.75	4.71	3.58
Other Current Liabilities	279.8	358.6	22.41	36.71	11.24
Total Current Liabilities	1,215	1,411	81.62	91.84	76.92
Long-Term Debt	33.3	30	70.89	0.99	1.92
Long-Term Leases	16.6	21.7	-	-	-
Long-Term Deferred Tax Liabilities	229	111.6	-	-	-
Other Long-Term Liabilities	1	0.4	-	-	-
Total Liabilities	1,501	1,579	155.26	92.82	80.04
Common Stock	58.9	14.7	10.85	10	0.1
Additional Paid-In Capital	504.3	504.7	41.65	-	-
Retained Earnings	571.9	337.1	138.86	55.78	30.36
Comprehensive Income & Other	1,424	720.4	-	-	-
Total Common Equity	2,559	1,577	191.36	65.78	30.46
Minority Interest	266.9	175.2	-	-	-
Shareholders' Equity	2,826	1,752	191.36	65.78	30.46
Total Liabilities & Equity	4,326	3,331	346.61	158.6	110.5
Total Debt	229.8	142.3	79.43	1.92	2.79
Net Cash (Debt)	42.9	107.3	-49.05	9.57	5.52
Net Cash Growth	-60.02%	-	-	73.48%	-34.24%
Net Cash Per Share	7.28	18.99	-6.00	1.20	0.69
Filing Date Shares Outstanding	5.83	11.78	8.68	8.68	8
Total Common Shares Outstanding	5.83	11.78	8.68	8.68	8
Working Capital	998.4	712.2	31.82	-14.9	-1.91
Book Value Per Share	438.94	133.82	22.05	7.58	3.81
Tangible Book Value	2,469	1,488	190.85	65.78	30.46
Tangible Book Value Per Share	423.52	126.23	21.99	7.58	3.81
Buildings	3.3	3.3	3.28	-	-
Machinery	69.7	35.8	31.07	7.89	7.18
Construction In Progress	-	0.1	0.22	-	-

Updated Nov 9, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.